Cargando…
Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
BACKGROUND: One limitation of anti-VEGF therapy is the need for monthly retreatment to maintain efficacy. The purpose of this study was to determine the duration of effect in eyes with macular edema (ME) secondary to branch or central retinal vein occlusion (BRVO or CRVO) treated with anti-VEGF ther...
Autores principales: | Singer, Michael A, Jansen, Michael E, Tyler, Lyndon, Woods, Paul, Ansari, Faisal, Jain, Udit, Singer, Joshua, Bell, Darren, Krambeer, Chelsey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182044/ https://www.ncbi.nlm.nih.gov/pubmed/28031700 http://dx.doi.org/10.2147/OPTH.S119373 |
Ejemplares similares
-
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
por: Gao, Lixiong, et al.
Publicado: (2019) -
The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
por: Wannamaker, Kendall W, et al.
Publicado: (2019) -
Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
por: Nghiem-Buffet, S, et al.
Publicado: (2017) -
Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion: A meta-analysis
por: Ji, Kaibao, et al.
Publicado: (2019) -
Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa
por: Pielen, Amelie, et al.
Publicado: (2017)